Metronom

Skip To Content

REVOLUTIONIZING CGM THROUGH INNOVATIVE TECHNOLOGY AND
PATIENT-CENTRIC DESIGN

Continuous Glucose Monitoring (CGM) is poised to replace traditional Self Blood Glucose Monitoring (SBGM) as the standard of care for people living with diabetes. Many factors will influence the shift from the traditional SBGM to CGM, and it is believed that technological advancements in CGM technologies and product offering will be a major driving force for this change. With only 10% of people living with Type 1 Diabetes using CGM technology as of 2017, and little to no penetration in people living with Type 2 Diabetes, there is a clear need for refinement and evolution of currently available Continuous Glucose Monitoring technology, enabling a greater, safer, and individualized user experience affordable to all.

For Continuous Glucose Monitoring (CGM) to gain broader adoption, the core technology and product design needs to address some of core user requirements, such as:

This is the system that Metronom Health is dedicated to building. 

THE METRONOM DIFFERENCE:
INDUSTRY-DISRUPTING TECHNOLOGY
AT ITS CORE

Unlike other CGMs currently available, Metronom’s approach to glucose sensing is different. Metronom’s opto-enzymatic technology utilizes Smart Sensing Methodology, which specifically addresses the challenges associated with sensing glucose in the body tissue environment. This simplifies or eliminates many of the burdensome procedures required to operate existing CGMs of which many utilize an electro-chemical technology. Some of Metronom’s technological benefits are:

CREATING THE METRONOM SOLUTION

Alert

You are now leaving the website of Metronom Health, Inc. and entering a third-party website over which Metronom Health, Inc. has no control. Neither Metronom Health, Inc. nor its subsidiaries or affiliates, are responsible for the content of third-party websites hyperlinked from this page or any hyperlink contained in a hyperlinked website, nor do they guarantee or endorse the information, recommendations, products or services offered on third-party websites.

Continue Cancel